Theunissen-de Neve SRL
Theunissen-de Neve reported total assets of 291,003 € at the end of the 2025 financial year (annual accounts filed with the NBB on 09 Dec 2025).
The score of Theunissen-de Neve shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -27 % Total assets -5 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Theunissen-de Neve's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −28,045 € | ||||
| Equity | 39,633 € | ||||
| Cash | 11,863 € | ||||
| EBITDA | −7,547 € | ||||
| Total assets | 291,003 € |
Filed annual accounts
- Year ended 30 Jun 2025filed on 09 Dec 2025
- Year ended 30 Jun 2024filed on 04 Oct 2024
- Year ended 30 Jun 2023filed on 23 Jan 2024
- Year ended 30 Jun 2022filed on 27 Jan 2023
- Year ended 30 Jun 2021filed on 07 Jan 2022
Theunissen-de Neve's financial analysis
- Solvency13.6%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Theunissen-de Neve
Theunissen-de Neve's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0827.921.229
- VAT number
- BE0827921229
- Peppol
- Registered · 0208:0827921229 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 19 Jul 2010
- Registered office
- 9300 Aalst
- Latest accounts
- 2025 · filed on 09 Dec 2025
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Theunissen-de Neve (SRL) has been based in Aalst since 2010, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 28,045 € and equity of 39,633 €; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Theunissen-de Neve
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Ambiorix Retail sale of pharmaceutical products Brussels · balance sheet 290,535 €
- AONA Retail sale of pharmaceutical products Roeselare · balance sheet 290,456 €
- Les Iles d'OR Retail sale of pharmaceutical products Woluwe-Saint-Lambert · balance sheet 291,796 €
- ACE Pharma Retail sale of pharmaceutical products Fexhe-le-Haut-Clocher · balance sheet 289,661 €
- Askela Retail sale of pharmaceutical products Chièvres · balance sheet 293,294 €
- Aksa Pharma Retail sale of pharmaceutical products Brussels · balance sheet 293,776 €
- Medipharm Anderlecht Retail sale of pharmaceutical products Evere · balance sheet 285,622 €
- Leveugle Retail sale of pharmaceutical products Deinze · balance sheet 297,608 €
Frequently asked questions about Theunissen-de Neve
What is the revenue of Theunissen-de Neve?
Theunissen-de Neve files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Theunissen-de Neve?
In Belgium, the VAT number is the company number prefixed with BE: BE0827921229 for Theunissen-de Neve, if the company is VAT-registered. Its company number (CBE) is 0827.921.229.
Where is the registered office of Theunissen-de Neve?
According to the CBE register, the registered office of Theunissen-de Neve is in 9300 Aalst.
What is the equity of Theunissen-de Neve?
At the close of the 2025 financial year, the equity of Theunissen-de Neve amounts to 39,633 €, a solvency of 13.6% of total assets.
Who manages Theunissen-de Neve?
The register lists 2 active mandates at Theunissen-de Neve. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Theunissen-de Neve
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →